vs
Side-by-side financial comparison of Legend Biotech Corp (LEGN) and TAL Education Group (TAL). Click either name above to swap in a different company.
Legend Biotech CorpLEGNEarnings & Financial Report
GenScript Biotech, fully known as GenScript Biotech Corporation, usually referred to as simply GenScript, is a China–based biotech company. It was co-founded in 2002 in New Jersey by Fangliang Zhang, Ye Wang, and Luquan Wang. The company mainly provides life science research application instruments and services. It was listed on the Hong Kong Stock Exchange in 2015. The current rotating CEO of the firm is Shao Weihui, who also served as the chief operating officer and Chinese Communist Party ...
TAL Education Group, which stands for "Tomorrow Advancing Life", is a Chinese holding company that offers after-school education and tutoring for students in primary and secondary school. It is headquartered in Beijing, China. The company was founded in August 2003 by Zhang Bangxin and Cao Yundong, as "Xueersi".
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $272.3M | — | ||
| Q2 25 | $255.1M | — | ||
| Q1 25 | $195.1M | — | ||
| Q3 24 | $160.2M | — | ||
| Q2 24 | $186.5M | — | ||
| Q1 24 | $94.0M | — | ||
| Q3 23 | $96.0M | — | ||
| Q2 23 | $73.3M | — |
| Q3 25 | $-39.7M | — | ||
| Q2 25 | $-125.4M | — | ||
| Q1 25 | $-100.9M | — | ||
| Q3 24 | $-125.3M | — | ||
| Q2 24 | $-18.2M | — | ||
| Q1 24 | $-59.8M | — | ||
| Q3 23 | $-62.2M | — | ||
| Q2 23 | $-199.1M | — |
| Q3 25 | 58.4% | — | ||
| Q2 25 | 62.8% | — | ||
| Q1 25 | 64.4% | — | ||
| Q3 24 | 67.2% | — | ||
| Q2 24 | 75.7% | — | ||
| Q1 24 | 47.8% | — | ||
| Q3 23 | 54.7% | — | ||
| Q2 23 | 55.4% | — |
| Q3 25 | -16.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | -43.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | -14.6% | — | ||
| Q2 25 | -49.2% | — | ||
| Q1 25 | -51.7% | — | ||
| Q3 24 | -78.2% | — | ||
| Q2 24 | -9.8% | — | ||
| Q1 24 | -63.6% | — | ||
| Q3 23 | -64.8% | — | ||
| Q2 23 | -271.6% | — |
| Q3 25 | $-0.11 | — | ||
| Q2 25 | $-0.34 | — | ||
| Q1 25 | $-0.27 | — | ||
| Q3 24 | $-0.34 | — | ||
| Q2 24 | $-0.05 | — | ||
| Q1 24 | $-0.16 | — | ||
| Q3 23 | $-0.16 | — | ||
| Q2 23 | $-0.57 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
